Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Elimination of drugs by active intestinal transport.

× No keyword cloud information.

8 in total

1. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man.

Authors: C G Regårdh; P Lundborg; M Gabrielsson; A Heggelund; K Kylberg-Hanssen
Journal: Pharm Res Date: 1990-12 Impact factor: 4.200

2. Effects of grapefruit juice on the pharmacokinetics of acebutolol.

Authors: Jari J Lilja; Kari Raaska; Pertti J Neuvonen
Journal: Br J Clin Pharmacol Date: 2005-12 Impact factor: 4.335

3. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.

Authors: J Karlsson; S M Kuo; J Ziemniak; P Artursson
Journal: Br J Pharmacol Date: 1993-11 Impact factor: 8.739

4. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

Authors: A Sparreboom; J van Asperen; U Mayer; A H Schinkel; J W Smit; D K Meijer; P Borst; W J Nooijen; J H Beijnen; O van Tellingen
Journal: Proc Natl Acad Sci U S A Date: 1997-03-04 Impact factor: 11.205

5. Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.

Authors: H Lennernäs; C G Regårdh
Journal: Pharm Res Date: 1993-05 Impact factor: 4.200

Elimination of drugs by active intestinal transport.

1. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man.

2. Effects of grapefruit juice on the pharmacokinetics of acebutolol.

3. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.

4. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

5. Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.

6. Acebutolol pharmacokinetics in renal failure.

7. The contribution of intestinal secretion to the dose-dependent absorption of celiprolol.

8. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats.